ID   COLO 845
AC   CVCL_L508
SY   COLO-845; Colo 845; COLO #845; COLO845; Colorado 845
DR   Wikidata; Q54814166
RX   PubMed=7780963;
RX   PubMed=8402545;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000027.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1137 ! COLO 829
OI   CVCL_1999 ! COLO 829BL
OI   CVCL_L503 ! COLO 831
OI   CVCL_2000 ! COLO 832
OI   CVCL_L504 ! COLO 833
OI   CVCL_L505 ! COLO 834
OI   CVCL_L506 ! COLO 835
OI   CVCL_L507 ! COLO 838
OI   CVCL_2001 ! COLO 839
OI   CVCL_L509 ! COLO 848
OI   CVCL_2002 ! COLO 849
OI   CVCL_2003 ! COLO 853
OI   CVCL_2004 ! COLO 857
OI   CVCL_2005 ! COLO 858
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
RX   PubMed=7780963;
RA   Easty D.J., Guthrie B.A., Maung K., Farr C.J., Lindberg R.A.,
RA   Toso R.J., Herlyn M., Bennett D.C.;
RT   "Protein B61 as a new growth factor: expression of B61 and
RT   up-regulation of its receptor epithelial cell kinase during melanoma
RT   progression.";
RL   Cancer Res. 55:2528-2532(1995).
//
RX   PubMed=8402545; DOI=10.1016/0165-4608(93)90083-X;
RA   Morse H.G., Moore G.E.;
RT   "Cytogenetic homogeneity in eight independent sites in a case of
RT   malignant melanoma.";
RL   Cancer Genet. Cytogenet. 69:108-112(1993).
//